Delivery Order SPE2DB20D3101-SPE2DB24FQTY9
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,965.02 firm-fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,534.21 fixed-price contract is for the supply of 4565220299 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of July 23, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONTRAVE ER 8-90 MG TABLET 120S. The firm-fixed-price delivery order has a ceiling value of $1,542.82 and a period of performance through March 19, 2025. The contract was not awarded under any set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,529.68 Firm Fixed Price delivery order contract is for the supply of CONTRAVE ER 8/90MG 120, a medication. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $15,954.35 and a performance period through June 25, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,554.45, is for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed-price pricing type and a period of performance through February 20, 2024. The contract is not designated as a set-aside. In addition to this delivery order,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,077.25, is a Delivery Order for the supply of CONTRAVE ER 8-90 MG TABLET 120S. It has a Firm Fixed Price pricing type and an ultimate completion date of March 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,892.61, is a delivery order for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2025. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The firm-fixed-price contract has a ceiling value of $3,964.96 and a completion date of April 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of the drug Contrave ER 8-90 mg tablets. The delivery order, valued at $5,367.46, is a firm-fixed-price contract with an ultimate completion date of October 24, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQTY9Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,879.04 firm-fixed-price contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has an ultimate completion date of November 2, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracting mechanisms enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 11/1/23 |